Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haloperidol and Lorazepam for Delirium in Advanced Cancer
NCT01949662Phase 2Active, not recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jan 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lorazepam in delirium, sponsored by University of Texas MD Anderson Cancer Center. Started Jan 2014; status: active, not recruiting.
02
Drugs
lorazepam
03
Conditions
delirium
Beyond the preview
Go deeper on NCT01949662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01949662.